Zai Lab Stock (NASDAQ: ZLAB) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 578.04K |
Day Range | - - - |
52 Wk Range | 13.48 - 31.22 |
Market Cap | $2.11B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 61 |
Short Interest | 5.48% |
Days to Cover | 8.06 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Zai Lab (NASDAQ:ZLAB) through any online brokerage.
Other companies in Zai Lab’s space includes: Centessa Pharmaceuticals (NASDAQ:CNTA), SpringWorks Therapeutics (NASDAQ:SWTX), Agios Pharmaceuticals (NASDAQ:AGIO), Arrowhead Pharma (NASDAQ:ARWR) and Kiniksa Pharmaceuticals (NASDAQ:KNSA).
Zai Lab has a consensus price target of $63.72.
The stock price for Zai Lab (NASDAQ: ZLAB) is $21.17 last updated September 20, 2024 at 4:52 PM EDT.
There are no upcoming dividends for Zai Lab.
Zai Lab’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
There is no upcoming split for Zai Lab.
Zai Lab is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.